Professor Jean-Charles Soria

General Director of Gustave Roussy from January 2020 to august 2021

Professor Jean-Charles Soria is a Medical Oncologist and Professor of Medicine at Paris-Saclay University. He holds a doctorate in molecular biology. He completed his training during a two year appointment at the MD Anderson Cancer Center in Houston, Texas, where in addition he was an associate professor from 2013 to 2017. He was also an elected member of the Oncology Section of the National University Council for 3 years and was the Director of the Gustave-Roussy SIRIC Socrate (Integrated Cancer Research Site) over 5 years (2012-2017). He studied health management at the Harvard Business School in 2017-2018. Over the last three years, Professor Soria has appeared in the list of the most influential research scientists in the world (Web of Science Group’s highly cited researchers). He is author or co-author of more than 630 articles in leading international journals.

Since September 2017, Professor Soria has been Senior Vice-President, Research & Development in Oncology, with AstraZeneca in Gaithersburg, Maryland, United States, where he leads research teams responsible for strategy and for development of new agents in immuno-oncology, cell therapy and conjugated antibodies.

During his career, Professor Soria has been the recipient of a number of prizes, the latest being the European Society for Medical Oncology (ESMO) award presented in 2018.

Professor Jean-Charles Soria was General Director of Gustave Roussy from January 6, 2020 to July 31, 2021, at which time he decided to end his term for family reasons.

In the summer of 2021, Professor Soria joins Amgen in Washington D.C., USA, as Senior Vice President Research & Development in the Oncology Therapeutics Department.